Fenofibrate-Induced Hyperhomocysteinaemia: Clinical Implications and Management

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.2, 2003-01, pp. : 81-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Micronised Fenofibrate: An Updated Review of its Clinical Efficacy in the Management of Dyslipidaemia

By Keating G.M. Ormrod D.

Drugs, Vol. 62, Iss. 13, 2002-01 ,pp. : 1909-1944

Adis International

Access to resources Recommend Favorite

Clinical Relevance of Hyperhomocysteinaemia in Atherothrombotic Disease

By Stehouwer C.D.A.

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 251-260

Adis International

Access to resources Recommend Favorite

Effect of fenofibrate on LDL-induced endothelial dysfunction in rats

By Yang Tian-Lun Chen Mei-Fang Luo Bai-Ling Yu Jing Jiang Jun-Lin Li Yuan-Jian

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 79-83

Springer Publishing Company

Access to resources Recommend Favorite

Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management

By Peter M. Haddad Angelika Wieck

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2291-2314

Adis International

Access to resources Recommend Favorite

Aspirin-Induced Asthma: Clinical Aspects, Pathogenesis and Management

By Ahmed M. Hamad

Drugs, Vol. 64, Iss. 21, 2004-01 ,pp. : 2417-2432

Adis International

Access to resources Recommend Favorite